Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 5.84 billion. The enterprise value is 7.77 billion.
| Market Cap | 5.84B |
| Enterprise Value | 7.77B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.47% |
| Owned by Institutions (%) | 38.09% |
| Float | 337.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 50.00 |
| PS Ratio | 1.75 |
| PB Ratio | 11.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 82.77 |
| P/OCF Ratio | 22.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.79, with an EV/FCF ratio of 110.18.
| EV / Earnings | n/a |
| EV / Sales | 2.33 |
| EV / EBITDA | 16.79 |
| EV / EBIT | 47.60 |
| EV / FCF | 110.18 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 3.85.
| Current Ratio | 0.79 |
| Quick Ratio | 0.55 |
| Debt / Equity | 3.85 |
| Debt / EBITDA | 4.37 |
| Debt / FCF | 28.69 |
| Interest Coverage | 1.65 |
Financial Efficiency
Return on equity (ROE) is -5.46% and return on invested capital (ROIC) is 6.86%.
| Return on Equity (ROE) | -5.46% |
| Return on Assets (ROA) | 3.16% |
| Return on Invested Capital (ROIC) | 6.86% |
| Return on Capital Employed (ROCE) | 6.85% |
| Weighted Average Cost of Capital (WACC) | 5.86% |
| Revenue Per Employee | 495,058 |
| Profits Per Employee | -2,072 |
| Employee Count | 6,962 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 11.14 |
Taxes
In the past 12 months, Med Life has paid 22.56 million in taxes.
| Income Tax | 22.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.66% in the last 52 weeks. The beta is 0.42, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +37.66% |
| 50-Day Moving Average | 11.90 |
| 200-Day Moving Average | 11.57 |
| Relative Strength Index (RSI) | 35.59 |
| Average Volume (20 Days) | 148,624 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 3.34 billion and -13.97 million in losses. Loss per share was -0.03.
| Revenue | 3.34B |
| Gross Profit | 1.62B |
| Operating Income | 163.26M |
| Pretax Income | -5.09M |
| Net Income | -13.97M |
| EBITDA | 360.38M |
| EBIT | 163.26M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 158.58 million in cash and 2.02 billion in debt, with a net cash position of -1.87 billion or -3.51 per share.
| Cash & Cash Equivalents | 158.58M |
| Total Debt | 2.02B |
| Net Cash | -1.87B |
| Net Cash Per Share | -3.51 |
| Equity (Book Value) | 525.29M |
| Book Value Per Share | 0.86 |
| Working Capital | -206.96M |
Cash Flow
In the last 12 months, operating cash flow was 263.34 million and capital expenditures -192.80 million, giving a free cash flow of 70.54 million.
| Operating Cash Flow | 263.34M |
| Capital Expenditures | -192.80M |
| Depreciation & Amortization | 197.12M |
| Net Borrowing | -6.19M |
| Free Cash Flow | 70.54M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 48.64%, with operating and profit margins of 4.89% and -0.42%.
| Gross Margin | 48.64% |
| Operating Margin | 4.89% |
| Pretax Margin | -0.15% |
| Profit Margin | -0.42% |
| EBITDA Margin | 10.79% |
| EBIT Margin | 4.89% |
| FCF Margin | 2.11% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.24% |
| FCF Yield | 1.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Med Life is 10.67, which is 0.66% higher than the current price. The consensus rating is "Hold".
| Price Target | 10.67 |
| Price Target Difference | 0.66% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 10.41% |
| EPS Growth Forecast (3Y) | 214.98% |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 2.22 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 6 |